Subsidies for the Basque Companies .

Filtra tu búsqueda

News 28 May, 2020

The Basque Government participates in the Research and production project for the vaccine against COVID 19, together with Harvard and the company VIRALGEN

Tapia highlights that, once Harvard advances with the vaccine, the Basque Country is ready to take on this opportunity that represents  a unique health, social and business advance

The Basque Government  is engaged in the international project to make this production possible in the Basque Country

Tapia highlights that, once Harvard advances with the vaccine, the Basque Country is ready to take on this opportunity that represents  a unique health, social and business advance

Viralgen Vector Core is a partnership uniquely positioned in the CDMO industry to bring forward a robust suspension platform for AAV production in a facility custom-designed to bring therapies to market as quickly as possible. Viralgen is able to support every aspect of your AAV program from start to finish, including large-scale manufacturing, fill-finish, and quality control in a GMP-certified environment in San Sebastian, Basque Country.

Harvard has chosen Viralgen Vector Core as it becomes the convergence point from experienced specialized organizations in biotechnology and life sciences, united with the aim of creating a CDMO in the cutting-edge sector of gene therapy and innovative medicines. Devoted to the Development and Manufacturing of viral vectors, in order to contribute to the progress in health and welfare of people.

Related news

CIC biomaGUNE launches a company that will transform disease diagnosis by using nanosensors
18/02/2025 I+D+i

CIC biomaGUNE launches a company that will transform disease diagnosis by using nanosensors

Taldeki Biosolutions will be developing sensors for rapid, cost-effective, robust antibody detection, thus overcoming the stability and cost problems of current in vitro diagnostics

VIVEbiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities
05/12/2024 Funding

VIVEbiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities

Support the execution of a robust pipeline of customer projects for innovators developing groundbreaking in vivo and ex vivo cell and gene therapies.

CIC nanoGUNE launches a new call: Industry Collaborative Research Positions
09/05/2024 R&D

CIC nanoGUNE launches a new call: Industry Collaborative Research Positions

Programa honen helburua da ikertzaile profesionalak tokiko erakundeetan sar daitezen erraztea

Companies with greater gender equality perform better in terms of innovation and are more competitive
16/04/2024 Innovation

Companies with greater gender equality perform better in terms of innovation and are more competitive

The study of the SPRI initiative "Women in Industry" shows that gender equality has an impact on the improvement of company results.

SPRI presents the results of the study on the impact of women on industrial competitiveness at the World Manufacturing Forum
28/11/2023 Innovation

SPRI presents the results of the study on the impact of women on industrial competitiveness at the World Manufacturing Forum

The reports is the continuation of the work carried out by the SPRI Group and the Foreign Network office in Milan since 2020 as leader of the Women in Manufacturing expert group.

Go to the blog section

Follow us

Specialized channels and daily news on our social profiles.